Literature DB >> 19620425

Imaging of tumor angiogenesis: functional or targeted?

Baris Turkbey1, Hisataka Kobayashi, Mikako Ogawa, Marcelino Bernardo, Peter L Choyke.   

Abstract

OBJECTIVE: Angiogenesis--the growth of new vessels--is both a normal physiologic response and a critical step in many pathologic processes, particularly cancer. Imaging has long relied on the different enhancement characteristics of cancer compared with normal tissue; the information generated is often primarily morphologic and qualitative. However, more quantitative methods based on functional and targeted imaging have recently emerged.
CONCLUSION: In this article, we review both functional and targeted imaging techniques for assessing tumor angiogenesis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19620425      PMCID： PMC3523171          DOI： 10.2214/AJR.09.2869

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  78 in total

1.  Cellular origin and molecular mechanisms of 18F-FDG uptake: is there a contribution of the endothelium?

Authors:  Andreas K Buck; Sven N Reske
Journal:  J Nucl Med       Date:  2004-03       Impact factor: 10.057

Review 2.  Perfusion CT for the assessment of tumour vascularity: which protocol?

Authors:  K A Miles
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

3.  Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

Authors:  Dilantha B Ellegala; Howard Leong-Poi; Joan E Carpenter; Alexander L Klibanov; Sanjiv Kaul; Mark E Shaffrey; Jiri Sklenar; Jonathan R Lindner
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

4.  Ovarian cancer detected non-invasively by contrast-enhanced power Doppler ultrasound.

Authors:  T J D'Arcy; V Jayaram; M Lynch; W P Soutter; D O Cosgrove; C J Harvey; N Patel
Journal:  BJOG       Date:  2004-06       Impact factor: 6.531

Review 5.  Imaging matrix metalloproteinase expression in tumors.

Authors:  W P Li; C J Anderson
Journal:  Q J Nucl Med       Date:  2003-09

6.  18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.

Authors:  Xiaoyuan Chen; Ryan Park; Anthony H Shahinian; Michel Tohme; Vazgen Khankaldyyan; Mohammed H Bozorgzadeh; James R Bading; Rex Moats; Walter E Laug; Peter S Conti
Journal:  Nucl Med Biol       Date:  2004-02       Impact factor: 2.408

7.  Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.

Authors:  Qi Huang Zheng; Xiangshu Fei; Xuan Liu; Ji Quan Wang; K Lee Stone; Tanya D Martinez; Dawn J Gay; Winston L Baity; Kathy D Miller; George W Sledge; Gary D Hutchins
Journal:  Nucl Med Biol       Date:  2004-01       Impact factor: 2.408

8.  Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers.

Authors:  Paula Wells; Terry Jones; Pat Price
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

Review 9.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

10.  Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane.

Authors:  H Anderson; J T Yap; P Wells; M P Miller; D Propper; P Price; A L Harris
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640
View more
  30 in total

1.  The role of magnetic resonance imaging in oncology.

Authors:  Concepción González Hernando; Laura Esteban; Teresa Cañas; Enrique Van den Brule; Miguel Pastrana
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 2.  Radionuclide imaging of perfusion and hypoxia.

Authors:  George Laking; Pat Price
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 3.  Imaging of perfusion using ultrasound.

Authors:  David Cosgrove; Nathalie Lassau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 4.  Functional magnetic resonance imaging of head and neck cancer: Performance and potential.

Authors:  Ahmed H El Beltagi; Ahmed H Elsotouhy; Ahmed M Own; Wael Abdelfattah; Kavitha Nair; Surjith Vattoth
Journal:  Neuroradiol J       Date:  2018-11-06

5.  The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy.

Authors:  Jyoti Roy; Frank Kuo; Falguni Basuli; Mark R Williams; Karen Wong; Michael V Green; Jurgen Seidel; Stephen S Adler; Biying Xu; Peter L Choyke; Elaine M Jagoda
Journal:  Cancer Biother Radiopharm       Date:  2019-02-15       Impact factor: 3.099

6.  Longitudinal in vivo monitoring of rodent glioma models through thinned skull using laser speckle contrast imaging.

Authors:  Abhishek Rege; Alan C Seifert; Dan Schlattman; Yu Ouyang; Khan W Li; Luca Basaldella; Henry Brem; Betty M Tyler; Nitish V Thakor
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

7.  Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge.

Authors:  Wei Huang; Xin Li; Yiyi Chen; Xia Li; Ming-Ching Chang; Matthew J Oborski; Dariya I Malyarenko; Mark Muzi; Guido H Jajamovich; Andriy Fedorov; Alina Tudorica; Sandeep N Gupta; Charles M Laymon; Kenneth I Marro; Hadrien A Dyvorne; James V Miller; Daniel P Barbodiak; Thomas L Chenevert; Thomas E Yankeelov; James M Mountz; Paul E Kinahan; Ron Kikinis; Bachir Taouli; Fiona Fennessy; Jayashree Kalpathy-Cramer
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

Review 8.  Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma.

Authors:  Jacobus F A Jansen; Jason A Koutcher; Amita Shukla-Dave
Journal:  Angiogenesis       Date:  2010-04-11       Impact factor: 9.596

9.  Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.

Authors:  Nilofer Azad; Minshu Yu; Ben Davidson; Peter Choyke; Clara C Chen; Bradford J Wood; Aradhana Venkatesan; Ryan Henning; Kathy Calvo; Lori Minasian; Daniel C Edelman; Paul Meltzer; Seth M Steinberg; Christina M Annunziata; Elise C Kohn
Journal:  Mol Cell Proteomics       Date:  2013-02-28       Impact factor: 5.911

Review 10.  Diagnosis of bowel diseases: the role of imaging and ultrasonography.

Authors:  Davide Roccarina; Matteo Garcovich; Maria Elena Ainora; Gianluigi Caracciolo; Francesca Ponziani; Antonio Gasbarrini; Maria Assunta Zocco
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.